Onconetix, Inc. Conversion of Stock, Shares Converted
Onconetix, Inc. (ONCO) had Conversion of Stock, Shares Converted of 5.88 thousand shares as of 2024-09-05, per its 10-K filed 2026-03-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2026-03-13
- 2024-09-05: Conversion of Stock, Shares Converted 5.88K shares; Conversion of Stock, Shares Converted as first filed 500.00K shares.
| Period end | Conversion of Stock, Shares Converted | Conversion of Stock, Shares Converted as first filed |
|---|---|---|
| 2024-09-05 | 5.88K shares 10-K · filed 2026-03-13 | 500.00K shares 10-Q · filed 2024-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |